Screening, docking, and molecular dynamics analysis of Mitragyna speciosa (Korth.) compounds for targeting HER2 in breast cancer

Breast cancer remains the most commonly diagnosed cancer among women worldwide, with approximately 2.3 million new cases reported in 2022. In the United States alone, an estimated 310,720 new cases of female breast cancer are expected in 2024. HER2-positive breast cancer, characterized by the overex...

Full description

Saved in:
Bibliographic Details
Main Authors: Nabila Hadiah Akbar, Farendina Suarantika, Taufik Muhammad Fakih, Ariranur Haniffadli, Khoirunnisa Muslimawati, Aditya Maulana Perdana Putra
Format: Article
Language:English
Published: Elsevier 2025-12-01
Series:Current Research in Structural Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2665928X2500008X
Tags: Add Tag
No Tags, Be the first to tag this record!